DiviDrip · HAE

HAE — Haemonetics Corporation

HAE is Haemonetics Corporation (Healthcare) — a non-dividend-paying stock. Trading at $103.96. Market cap: $4.73B. Capital Quality Rank: 79/100 — Elite compounder.

Stock snapshot

Price$103.96
Market cap$4.73B
SectorHealthcare
ExchangeNYQ
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)79 / 100 · Elite compounder
ROIC (TTM)7.0%
Revenue CAGR (3y)4.5%
Shareholder buyback yield7.13%
Altman Z-score zoneGrey

About HAE

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Listed1991Employees3.0KHQBoston, MASectorHealthcareWebsitehaemonetics.com

Related non-dividend companies

Other non-dividend stocks investors research alongside HAE. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is HAE's current stock price?

HAE (Haemonetics Corporation) is currently trading at $103.96.

Does HAE pay a dividend?

HAE (Haemonetics Corporation) does not currently pay a regular dividend.

What is HAE's Capital Quality Rank?

HAE has a Capital Quality Rank of 79/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track HAE in DiviDrip

Add HAE to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow